Pyrosequencing™-based screening for the genetic polymorphism CYP2B6 1459 C>T

被引:0
|
作者
Doehring, Alexandra [1 ]
Loetsch, Joern [1 ]
机构
[1] Goethe Univ Frankfurt, Pharmazentrum Frankfurt ZAFES, Inst Clin Pharmacol, D-60590 Frankfurt, Germany
关键词
CYTOCHROME P4502B6; THERAPY;
D O I
10.2217/PGS.09.123
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:1577 / 1579
页数:3
相关论文
共 50 条
  • [41] Direct sequencing and comprehensive screening of genetic polymorphisms on CYP2 family genes (CYP2A6, CYP2B6, CYP2C8, and CYP2E1) in five ethnic populations
    Kim, Jeong-Hyun
    Cheong, Hyun Sub
    Park, Byung Lae
    Kim, Lyoung Hyo
    Shin, Hee Jung
    Na, Han Sung
    Chung, Myeon Woo
    Shin, Hyoung Doo
    ARCHIVES OF PHARMACAL RESEARCH, 2015, 38 (01) : 115 - 128
  • [42] Genetic polymorphism of DNA methyltransferase 3B 149 C>T and risk of colorectal cancer: a meta-analysis
    Meng, Qingkai
    Zhang, Jingru
    Lian, Bo
    Song, Chun
    TUMOR BIOLOGY, 2014, 35 (03) : 2367 - 2372
  • [43] Psoralen, a mechanism-based inactivator of CYP2B6
    Ji, Lin
    Lu, Dan
    Cao, Jiaojiao
    Zheng, Liwei
    Peng, Ying
    Zheng, Jiang
    CHEMICO-BIOLOGICAL INTERACTIONS, 2015, 240 : 346 - 352
  • [44] VARIABILITY IN SERTRALINE PHARMACOKINETICS EXPLAINED BY CYP2C19 AND CYP2B6
    Ramsey, Laura B.
    Poweleit, Ethan A.
    Vaughn, Samuel
    Momper, Jeremiah
    Desta, Zeruesenay
    Strawn, Jeffrey Robert
    JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2024, 63 (10): : S194 - S194
  • [45] The role of CYP2B6 516G>T polymorphism on efavirenz/nevirapine toxicity. Implications on treatment outcomes Lessons from Botswana
    Maseng, Monkgomotsi J.
    Tawe, Leabaneng
    Thami, Prisca K.
    Moyo, Sikhulile
    Kasvosve, Ishmael
    Novitsky, Vladimir
    Essex, Max
    Russo, Gianluca
    Gaseitsiwe, Simani
    Paganotti, Giacomo M.
    MEDICINE, 2022, 101 (17) : E29066
  • [46] Occurrence of CYP2B6 516G>T polymorphism in patients with ARV-associated hepatotoxicity
    Singh, HariOm
    Lata, Sonam
    Dhole, T. N.
    Gangakhedkar, Raman R.
    MOLECULAR GENETICS & GENOMIC MEDICINE, 2019, 7 (04):
  • [47] Association of CYP2B6 (G15631T) polymorphism with Clopidogrel resistance and genetic predisposition to Acute Coronary Syndromes (ACSs) in Morocco
    Hassani Idrissi, Hind
    El Khorb, Nada
    Akoudad, Abdelhafid
    Habbal, Rachida
    Nadifi, Sellama
    GENE REPORTS, 2018, 11 : 244 - 249
  • [48] Oxypeucedanin is a Mechanism-based Inactivator of CYP2B6 and CYP2D6
    Zhang, Kehan
    Li, Yilin
    Fu, Yao
    Cui, Tiantian
    Wang, Qian
    Mao, Xu
    Peng, Ying
    Zheng, Jiang
    CURRENT DRUG METABOLISM, 2021, 22 (11) : 882 - 892
  • [49] Imperatorin Is a Mechanism-Based Inactivator of CYP2B6
    Zheng, Liwei
    Cao, Jiaojiao
    Lu, Dan
    Ji, Lin
    Peng, Ying
    Zheng, Jiang
    DRUG METABOLISM AND DISPOSITION, 2015, 43 (01) : 82 - 88
  • [50] Mir-196a-2 C>T polymorphism as a susceptibility factor for colorectal cancer
    Shi, Liang
    Zhang, Chongyang
    Zhao, Dongqiang
    Liu, Kexia
    Li, Tiejun
    Tian, Hui
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2015, 8 (02): : 2600 - 2606